rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Sanara MedTech Inc.

SMTI · Nasdaq

Health CareMedical DevicesLeading

SMTI stood above a rising 150-day average in 15 of the last 52 weekly readings, including each of the last 15 weeks. It is 26.1% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
15 in a row
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
72 (+11)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 15 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders72+11 on the quarter
New · exited18 · 6
Reported value$41.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 2026248,827$5.9M+20,060+8.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026194,897$4.6M+43,530+28.8%
ROYAL BANK OF CANADAreduced · filed 14 Aug 2026130,995$3.1M-394−0.3%
Stonebridge Wealth Management, LLCreduced · filed 17 Jul 2026129,452$3.1M-7,447−5.4%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026112,207$2.6M+72,269+181.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202689,179$2.1M+3,517+4.1%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 202674,198$1.8M+52,613+243.7%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 202667,400$1.6M+2,720+4.2%
STATE STREET CORPadded · filed 7 Aug 202663,469$1.5M+780+1.2%
Squarepoint Ops LLCreduced · filed 14 Aug 202653,811$1.3M-19,796−26.9%
31 Mar 2023 – 30 Jun 2026
315170Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Seth D. Yon Company insiderChief Executive Officer · last 15 Sep 20260 · 0
Ann Beal Salamone Company insiderDirector · last 4 Jun 20260 · 0
Eric D. Major Company insiderDirector · last 4 Jun 20260 · 0
Eric D. Tanzberger Company insiderDirector · last 4 Jun 20260 · 0
Keith G. Myers Company insiderDirector · last 4 Jun 20260 · 0
Robert Andrew DeSutter Company insiderDirector · last 4 Jun 20260 · 0
Ronald T. Nixon Company insiderDirector, 10% owner · last 4 Jun 20261 · 0
Roszell Mack III Company insiderDirector · last 4 Jun 20260 · 0
Sara N. Ortwein Company insiderDirector · last 4 Jun 20260 · 0
Jacob A. Waldrop Company insiderChief Operating Officer · last 15 Apr 20260 · 0
Ashley M. Mackey Company insiderController · last 22 Mar 20260 · 0
Elizabeth B. Taylor Company insiderChief Financial Officer · last 22 Mar 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202592.7%
Operating profit marginFY 2025 · to 31 Dec 20257.1%
Free cash flow marginFY 2025 · to 31 Dec 20252.1%
Return on capital employedFY 2025 · to 31 Dec 202513.4%
Debt to equityFY 2025 · to 31 Dec 20257.74×
Interest coverFY 2025 · to 31 Dec 20251.08×
Research spendFY 2025 · to 31 Dec 20254.9%
Share count trendFY 2025 · to 20 Mar 20262.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$16.6M
Free cash flowFY 2025 · to 31 Dec 2025$2.2M

Analyst forecasts

No analyst forecasts yet.